Atypical Hemolytic Uremic Syndrome Associated with BNT162b2 mRNA COVID-19 Vaccine in a Kidney Transplant Recipient: A Case Report and Literature Review

被引:0
|
作者
Pattonieri, Eleonora Francesca [1 ]
Gregorini, Marilena [1 ,2 ]
Grignano, Maria Antonietta [1 ]
Islami, Tefik [1 ]
D'Ambrosio, Gioacchino [3 ,4 ]
Ardissino, Gianluigi [5 ]
Rampino, Teresa [1 ,2 ]
机构
[1] Fdn IRCCS Policlin San Matteo, Unit Nephrol Dialysis & Transplants, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Internal Med & Therapeut, I-27100 Pavia, Italy
[3] Univ Pavia, Dept Mol Med, Anat Pathol Unit, I-27100 Pavia, Italy
[4] Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
[5] Fdn IRCCS CaGranda Osped Maggiore Policlin, Ctr HUS Prevent Control & Management, I-20162 Milan, Italy
关键词
BNT162b2; COVID-19; vaccination; hemolytic uremic syndrome; acute kidney injury; kidney transplant;
D O I
10.3390/idr17010014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Case Report: We report a case of a 37-year-old female with kidney transplant, who was admitted at our hospital due to worsening renal function, nephrotic proteinuria, and anemia developed 21 days after the second dose of BNT162b2 COVID-19 vaccine (Pfizer-BioNTech). Laboratory tests revealed hemolytic anemia, thrombocytopenia, and acute kidney injury. Given the clinical picture of Thrombotic Micro-angiopathy (TMA) and severe renal impairment, plasma exchange (PEX) and dialysis were immediately started. Laboratory workup showed low C3 and C4 levels, normal activity of ADAMTS13, and the absence of anti-factor H antibodies. Molecular biology investigations revealed a heterozygous variant in exon 22 (SCR20) of the CFH gene (c.3628C>T; p.Arg1210Cys) described as an atypical Hemolytic Uremic Syndrome (aHUS) causative mutation. Our patient completed two sessions of PEX followed by eculizumab treatment with hematological improvement but no recovery of renal function. This is the first reported case of aHUS triggered by SARS-CoV-2 vaccination in a kidney transplant patient without recovery of renal function. Conclusion: Although rare, clinicians should be aware of possible nephrological complications that may appear after vaccination.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration
    Atak, Mehmet Fatih
    Farabi, Banu
    Kalelioglu, Mehmet Berati
    Rao, Babar K.
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (02) : 435 - 437
  • [42] 'Blue toes' following vaccination with the Pfizer BNT162b2 mRNA COVID-19 vaccine
    Davido, Benjamin
    Mascitti, Helene
    Fortier-Beaulieu, Marc
    Jaffal, Karim
    de Truchis, Pierre
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (04)
  • [43] Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine
    Snapiri, Ori
    Danziger, Chen Rosenberg
    Shirman, Nina
    Weissbach, Avichai
    Lowenthal, Alexander
    Ayalon, Itay
    Adam, Dganit
    Yarden-Bilavsky, Havatzelet
    Bilavsky, Efraim
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (10) : E360 - E363
  • [44] CMR Imaging 6 Months After Myocarditis Associated with the BNT162b2 mRNA COVID-19 Vaccine
    Amir, Gabriel
    Rotstein, Amichai
    Razon, Yaron
    Beyersdorf, Gil Beer
    Barak-Corren, Yuval
    Godfrey, Max E.
    Lakovsky, Yaniv
    Yaeger-Yarom, Gili
    Yarden-Bilavsky, Havazelet
    Birk, Einat
    PEDIATRIC CARDIOLOGY, 2022, 43 (07) : 1522 - 1529
  • [45] Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine
    Akiyama, Hiroaki
    Kakiuchi, Seiji
    Rikitake, Junpei
    Matsuba, Hiroyuki
    Sekinada, Daisuke
    Kozuki, Yoko
    Iwata, Nobuko
    IDCASES, 2021, 25
  • [46] Clinicopathological Characteristics of Autoimmune-Like Hepatitis Induced by COVID-19 mRNA Vaccine (Pfizer-BioNTech, BNT162b2): A Case Report and Literature Review
    Kim, Ji Hyoun
    Chae, Hee Bok
    Woo, Sumin
    Song, Myung Seop
    Kim, Hyo-Jong
    Woo, Chang Gok
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2023, 31 (06) : 1156 - 1162
  • [47] COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS)
    Ludwikowska, Kamila M.
    Popiel, Aneta
    Matkowska-Kocjan, Agnieszka
    Biela, Mateusz
    Wojcik, Marta
    Szenborn, Filip
    Wielgos, Katarzyna
    Pielka-Markiewicz, Ewa
    Zaryczanski, Janusz
    Kursa, Miron B.
    Szenborn, Leszek
    VACCINE, 2023, 41 (21) : 3317 - 3327
  • [48] Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever
    Shechtman, Liran
    Lahad, Karney
    Livneh, Avi
    Grossman, Chagai
    Druyan, Amit
    Giat, Eitan
    Lidar, Merav
    Freund, Sarit
    Manor, Uri
    Pomerantz, Alon
    Veroslavski, Daniel
    Ben-Zvi, Ilan
    RHEUMATOLOGY, 2022, 61 (SI2) : SI129 - SI135
  • [49] Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
    Havlin, Jan
    Svorcova, Monika
    Dvorackova, Eliska
    Lastovicka, Jan
    Lischke, Robert
    Kalina, Tomas
    Hubacek, Petr
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (08) : 754 - 758
  • [50] A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19
    Moerz, Michael
    VACCINES, 2022, 10 (10)